Drdgold Cash & Equivalents Growth & History (DRD)

Drdgold's cash and equivalents was R2.77B for fiscal 2026.

View full Drdgold company overview

Drdgold annual cash and equivalents history

Drdgold annual cash and equivalents

Fiscal yearPeriod endedCash and equivalentsChangeGrowth
20262026-06-30R2.77BR1.46B+112.07%
20252025-06-30R1.31BR784.7M+150.47%
20242024-06-30R521.5M−R1.95B−78.90%
20232023-06-30R2.47B−R54.2M−2.15%
20222022-06-30R2.53BR345.6M+15.85%
20212021-06-30R2.18BR464.9M+27.11%
20202020-06-30R1.72BR1.44B+513.63%
20192019-06-30R279.5M−R22.6M−7.48%
20182018-06-30R302.1MR48.4M+19.08%
20172017-06-30R253.7M−R98.1M−27.89%
20162016-06-30R351.8M

Drdgold cash and equivalents trends

Over the last five fiscal years, Drdgold's cash and equivalents increased from R2.18B to R2.77B, a change of R590.0M. The latest reported quarter, Q4 2025, shows R1.31B.

About the metric

What cash and equivalents mean

Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.

Calculation and source

Reported cash and equivalents

TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Drdgold source filings ↗

Community posts

It’s quiet here.

No posts about DRD yet. Start the conversation.

Write the first post